Feedback / Questions
Columvi (glofitamab-gxbm) - Roche
Polivy (polatuzumab vedotin-piiq) - Roche
Columvi + Polivy: Regulatory submission in Japan for previously treated LBCL in 2028
(Chugai)
-
Oct 27, 2026 -
Q3 FY2026 Results
Japan filing
•
Hematological Malignancies • Large B Cell Lymphoma • Oncology
https://www.chugai-pharm.co.jp/cont_file_dl.php?f=FILE_5_77.pdf&src=[%0],[%1]&rep=137,77
Oct 27, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next